BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Activity
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

34 hedge funds and large institutions have $5.76M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+12
Holders Change %
+54.55%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
3
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
Ikarian Capital
Texas
$1.77M
2
SM
Sabby Management
Florida
$563K
3
AFM
Anson Funds Management
Texas
$350K
4
GCP
GSA Capital Partners
United Kingdom
$235K
5
BFM
Boothbay Fund Management
New York
$187K

Top Sellers

1
FM
Frazier Management
Washington
$0
2
Renaissance Technologies
Renaissance Technologies
New York
$94K
3
Principal Financial Group
Principal Financial Group
Iowa
$0
4
BCM
Bridgeway Capital Management
Texas
$0
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
$56K
Name Holding Trade Value Shares
Change 		Shares
Change %
AF
26
Allworth Financial
California
$1K +$1K +300 New
PAM
27
Panagora Asset Management
Massachusetts
$1K +$1K +324 New
FM
28
Frazier Management
Washington
– -$691K -105,144 Closed
Principal Financial Group
29
Principal Financial Group
Iowa
– -$362K -54,978 Closed
BCM
30
Bridgeway Capital Management
Texas
– -$190K -28,900 Closed
Bank of America
31
Bank of America
North Carolina
– -$4K -681 Closed
Bank Julius Baer & Co
32
Bank Julius Baer & Co
Switzerland
– -$1K -120 Closed
1
2